IL-23IL-23

Back to Disease

How is Guselkumab dosed in PsO, PsA, and IBD

Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.

What is The Role of IL23/IL17 Axis in Rheumatic Disease

Describe the IL23/IL17 Axis

Describe The Mechanism of Action of Guselkumab

Define, Compare, and Contrast Humoral and Cell-Mediated Immunity

What is Non-Responder Imputation and How is it Utilized in Clinical Trials

Data review from the Phase III Discover-2 Trials

Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play